Article

A rhinovirus vaccine evokes T cell mediated cross-reactive immunity in a preclinical model of rhinovirus infection

2026-01-07

Abstract excerpt

Rhinovirus (RV) infection is the most common cause of acute exacerbations of respiratory diseases such as asthma and chronic obstructive pulmonary disease. Vaccines are available for two less common respiratory viruses (influenza and respiratory syncytial viruses), but development of a RV vaccine to protect patients with chronic respiratory disease has been hampered by the large number of serologically distinct RV...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6c48b08c-7068-5289-a317-a506a6add1fd
DOI: 10.64898/2026.01.06.697896

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A rhinovirus vaccine evokes T cell mediated cross-reactive immunity in a preclinical model of rhinovirus infectionDOI 10.64898/2026.01.06.697896Read

Cross-Serotype Immunity Induced by Immunization with a Conserved Rhinovirus Capsid ProteinSemantic proximity Read

Recent advances in understanding rhinovirus immunitySemantic proximity Read

The rhinovirus puzzle: Linking virus and host factors to childhood asthma.Semantic proximity Read

Induction of neutralising antibodies against conserved rhinovirus capsid protein VP4 depends on presenting VP4 in a virus-like conformationSemantic proximity Read

50-valent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaquesSemantic proximity Read

Human rhinovirus‐specific CD8 T cell responses target conserved and unusual epitopesSemantic proximity Read

Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathologySemantic proximity Read

A Safe and Effective Mucosal RSV Vaccine Consisting of RSV Phosphoprotein and Flagellin VariantSemantic proximity Read

Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine DevelopmentSemantic proximity Read

Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisationSemantic proximity Read

A safe and effective mucosal RSV vaccine in mice consisting of RSV phosphoprotein and flagellin variant.Semantic proximity Read

New mucosal bivalent live-attenuated vaccine is protective against Human Metapneumovirus and Respiratory Syncytial VirusSemantic proximity Read